UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis

Journal of cancer research and clinical oncology, 2003-03, Vol.129 (3), p.161-164

2003

Volltextzugriff (PDF)

Heterogeneity of proteinkinase C activity and PKC-ζ expression in clinical breast carcinomas

Clinical and experimental medicine, 2001-03, Vol.1 (1), p.1-8

2001

Volltextzugriff (PDF)

Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours

Cancer Immunology, Immunotherapy, 1997-04, Vol.44 (2), p.88-96

1997

Volltextzugriff (PDF)

PTEN mutations do not cause nuclear β-catenin accumulation in endometrial carcinomas

Human pathology, 2004-10, Vol.35 (10), p.1260-1265

2004

Volltextzugriff (PDF)

Time to progression is dependent on the expression of the tumour suppressor PTEN in ovarian cancer patients

European journal of clinical investigation, 2003-03, Vol.33 (3), p.256-260

2003

Volltextzugriff (PDF)

Weekly Carboplatin and Docetaxel for Locally Advanced Primary and Recurrent Cervical Cancer: A Phase I Study

Gynecologic oncology, 2002-10, Vol.87 (1), p.98-103

2002

Volltextzugriff (PDF)

Amplification of the mdr1-gene is uncommon in recurrent ovarian carcinomas

Cancer letters, 1999-11, Vol.146 (2), p.195-199

1999

Volltextzugriff (PDF)

H-ras gene amplification or mutation is not common in human primary breast cancer

Oncology reports, 1999-09, Vol.6 (5), p.1029

1999

Volltextzugriff (PDF)

p21waf correlates with DNA replication but not with prognosis in invasive breast cancer

Journal of clinical pathology, 2001-11, Vol.54 (11), p.866-870

2001

Volltextzugriff (PDF)

PTEN mutations do not cause nuclear [beta]-catenin accumulation in endometrial carcinomas

Human pathology, 2004-10, Vol.35 (10), p.1260

2004

Volltextzugriff (PDF)

Immunohistochemical Detection of H-ras Protooncoprotein p21 Indicates Favorable Prognosis in Node-Negative Breast Cancer Patients

Tumor biology, 1999-07, Vol.20 (4), p.173-183

1999

Volltextzugriff (PDF)

Hypermethylation of the PTEN gene in ovarian cancer cell lines

Cancer letters, 2004-04, Vol.207 (2), p.215-220

2004

Volltextzugriff (PDF)

Immunologic features of tumor-infiltrating lymphocytes and peripheral blood lymphocytes in ovarian cancer patients

Journal of the Society for Gynecologic Investigation, 1998-03, Vol.5 (2), p.102-107

1998

Volltextzugriff (PDF)

Serologic concentrations of HER-2/neu in breast cancer patients with visceral metastases receiving trastuzumab therapy predict the clinical course

Clinical chemistry (Baltimore, Md.), 2002-08, Vol.48 (8), p.1360-1362

2002

Volltextzugriff (PDF)

Recurrence of breast cancer in the donor site after latissimus dorsi flap

Plastic and reconstructive surgery (1963), 2003-09, Vol.112 (3), p.819-821

2003

Volltextzugriff (PDF)

Association of the Vitamin D Receptor Genotype with Bone Metastases in Breast Cancer Patients

Oncology, 2003-01, Vol.64 (2), p.154-159

2003

Volltextzugriff (PDF)

Immunohistochemical analysis reveals a protective effect of H-ras expression mediated via apoptosis in node-negative breast cancer patients

International journal of oncology, 2002-02, Vol.20 (2), p.273

2002

Volltextzugriff (PDF)

Lack of prognostic significance of nm23 expression in human primary breast cancer

Oncology reports, 2002-11, Vol.9 (6), p.1205

2002

Volltextzugriff (PDF)

Detection of Chromosomal Aberrations in Tumor Cells and Tumor Infiltrating Lymphocytes by Molecular Cytogenetics in Patients with Gynecological Cancer

Cancer genetics and cytogenetics, 1998-10, Vol.106 (2), p.159-165

1998

Volltextzugriff (PDF)

Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer

Journal of cancer research and clinical oncology, 2012-04, Vol.138 (4), p.603-610

2012

Volltextzugriff (PDF)

A new targeting approach for breast cancer gene therapy using the Heparanase promoter

Cancer letters, 2006-08, Vol.240 (1), p.114-122

2006

Volltextzugriff (PDF)

Expression of the tumor suppressor gene PTEN is not altered in the progression of ovarian carcinomas and does not correlate with p27Kip1 expression

Oncology reports, 2003-11, Vol.10 (6), p.1717

2003

Volltextzugriff (PDF)

Determining the nuclear area in normal breast epithelia and in the nuclei of mammary carcinomas

Journal of cancer research and clinical oncology, 1985, Vol.109 (3), p.241-244

1985

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis

Heterogeneity of proteinkinase C activity and PKC-ζ expression in clinical breast carcinomas

Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours

PTEN mutations do not cause nuclear β-catenin accumulation in endometrial carcinomas

Time to progression is dependent on the expression of the tumour suppressor PTEN in ovarian cancer patients

Weekly Carboplatin and Docetaxel for Locally Advanced Primary and Recurrent Cervical Cancer: A Phase I Study

Amplification of the mdr1-gene is uncommon in recurrent ovarian carcinomas

H-ras gene amplification or mutation is not common in human primary breast cancer

p21waf correlates with DNA replication but not with prognosis in invasive breast cancer

PTEN mutations do not cause nuclear [beta]-catenin accumulation in endometrial carcinomas

Immunohistochemical Detection of H-ras Protooncoprotein p21 Indicates Favorable Prognosis in Node-Negative Breast Cancer Patients

Hypermethylation of the PTEN gene in ovarian cancer cell lines

Immunologic features of tumor-infiltrating lymphocytes and peripheral blood lymphocytes in ovarian cancer patients

Serologic concentrations of HER-2/neu in breast cancer patients with visceral metastases receiving trastuzumab therapy predict the clinical course

Recurrence of breast cancer in the donor site after latissimus dorsi flap

Association of the Vitamin D Receptor Genotype with Bone Metastases in Breast Cancer Patients

Immunohistochemical analysis reveals a protective effect of H-ras expression mediated via apoptosis in node-negative breast cancer patients

Lack of prognostic significance of nm23 expression in human primary breast cancer

Detection of Chromosomal Aberrations in Tumor Cells and Tumor Infiltrating Lymphocytes by Molecular Cytogenetics in Patients with Gynecological Cancer

Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer

A new targeting approach for breast cancer gene therapy using the Heparanase promoter

Expression of the tumor suppressor gene PTEN is not altered in the progression of ovarian carcinomas and does not correlate with p27Kip1 expression

Determining the nuclear area in normal breast epithelia and in the nuclei of mammary carcinomas

Aktive Filter

Suchergebnisse filtern